CIK 0001006281 · Non-accelerated filer<br>Smaller reporting company
Protalix BioTherapeutics, Inc.
Sign in to watch- Ticker
- PLX
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 650643773
- Phone
- 201-696-9345
- Business address
- 2 UNIVERSITY PLAZA, SUITE 100, HACKENSACK, NJ, 07601
- Former names
- ORTHODONTIX INC, EMBASSY ACQUISITION CORP
- 4 Open-market buy Director bought 110,000 shares at $1.42 ($155,815)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy President and CEO bought 68,000 shares at $1.50 ($102,000)
- 4 Grant or award Sr. VP and CFO acquired 121,951 shares (grant or award)
- 4 Grant or award President and CEO acquired 637,531 shares (grant or award)
- 4 Open-market sale 10% owner sold 918,717 shares at an average $2.27 ($2,088,857)
- 3 Insider Initial Statement of Ownership
- 4/A Grant or award Sr. VP and CFO acquired 246,146 shares (grant or award)
- 4/A Grant or award President and CEO acquired 447,927 shares (grant or award)
Page 3 of 12 · 223 filings